ArticleCancers2022

The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status.

Heather Poad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.